Xtant Medical EV/EBIT XTNT

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2019.

Today, Oct 23, 2026: n/m; an operating loss
Last meaningful: 18.8×; Aug 2026
7-year median: 13.5×
7-year range: 2.2× to 223×
Peer median: 8.2×

Xtant Medical has no meaningful EV/EBIT today: it made an operating loss of $10.5M over the last twelve months.

It was last meaningful in Aug 2026, at 18.8×.

On the days it had one over the last 7 years, its median was 13.5×, from 2.2× in Apr 2020 to 223× in Jun 2021.

EV/EBIT over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	18.8×	8.9×	20.3×
2025	18.2×	14.1×	18.2×
2024	n/m a value too high to mean anything
2023	n/m a value too high to mean anything
2022	n/m a value too high to mean anything
2021	179×	142×	223×
2020	2.3×	2.2×	3.0×
2019	3.1×	3.0×	3.8×

Against its peers

Companies in Medical - Instruments & Supplies nearest Xtant Medical's size, closest first, today.

Company	EV/EBIT
XTNTXtant Medical	n/m
NEPHNephros	20.5×
APTAlpha Pro Tech	8.2×
KEQUKewaunee Scientific	7.2×
PDEXPro DEX	16.0×
UTMDUtah Medical Products	6.0×
INFUInfuSystem	22.4×
EMBCEmbecta	6.7×
Peer median	8.2×

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Xtant Medical

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.